Cytel Launches East Horizon™ Platform: Advancing the Science of Adaptive Clinical Trial Design and Simulation
September 30, 2024 09:42 ET
|
Cytel
Cambridge, MA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Cytel, a leader in statistical software and advanced quantitative solutions for clinical research, announces the release of East Horizon™, an...
In a First for Pharma, Citeline SmartSolutions Take AI to New Levels, Optimizing Clinical Trial Planning and Site Selection
August 13, 2024 09:00 ET
|
Citeline
Citeline has Protocol SmartDesign and Investigator SmartSelect, part of its AI-enabled SmartSolutions suite accelerating the path from pipeline to patient.
Innovative AI-enabled Clinical Trial Strategic Profiling Report 2024: Integration of Real-world Insights into Trial Management is Propelling AI Adoption in Clinical Trials
August 06, 2024 05:40 ET
|
Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities" report has been added to ResearchAndMarkets.com's...
Global CLL Therapeutics Market Set to Reach $9.2 Billion by 2032
March 25, 2024 11:14 ET
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been...
Clinical Trials Industry Experiences Growth: Insightful Analysis on Trial Descriptors
January 24, 2024 00:53 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trials - Lessons from Trial Descriptors" report has been added to ResearchAndMarkets.com's offering. The world of clinical trials...
von Willebrand Disease (vWD) Therapeutics Market Analysis 2023-2032: Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs
January 23, 2024 16:53 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032" report...
Chronic Lymphocytic Leukemia Industry Outlook to 2032: Regional Market Opportunity Assessments, Epidemiology, Clinical Trials, Unmet Needs, Competitive Landscape Analysis
January 23, 2024 15:38 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been...
Global Clinical Trial Imaging Market Report 2024-2030 Featuring Key Players Ixico, Navitas Life Sciences, Resonance Health, Proscan Imaging & Medpace
December 21, 2023 09:23 ET
|
Research and Markets
Dublin, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Imaging Market Size, Share & Trends Analysis Report by Service (Clinical Trial Design & Consultation Services, Reading...
Acute Myeloid Leukemia (AML) Therapeutics Market Set to Reach $3.7 Billion by 2032: New Pipeline Agents Drive Growth
October 31, 2023 08:58 ET
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032" report has been added to ...
Parkinson's Disease Market Outlook: Epidemiology, Treatment, and Pipeline Analysis
August 10, 2023 09:33 ET
|
Research and Markets
Dublin, Aug. 10, 2023 (GLOBE NEWSWIRE) -- The "Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs,...